Operator of a biopharmaceutical company in Sweden. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of Cytomegalovirus (CMV).
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 05-Jan-2015 | Completed | Pre-Clinical Trials | |||
1. Early Stage VC | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Christian Schaub | Managing Director |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Redalpine Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |